José J. Fuster graduated in Biochemistry from the University of Valencia, Spain, in 2005, and subsequently completed his Ph.D. at the same institution in 2010, based on research conducted at the Institute of Biomedicine of Valencia (IBV-CSIC). In 2011, he took a Postdoctoral Associate position in Boston University School of Medicine (USA, investigating the interplay between adipose tissue and the vascular wall in the contexts of obesity and aging. In 2015, he was appointed as Instructor in the Department of Medicine at Boston University, a Junior Faculty position that allowed him to establish a new line of research focused on investigating the contribution of somatic mutations in blood cells to cardiovascular disease. As part of this line of research, he provided the first experimental evidence supporting that somatic mutations that drive clonal hematopoiesis contribute directly to the development of atherosclerosis.
After holding Assistant Professor positions at Boston University and the University of Virginia (2017-2018), Dr. Fuster joined CNIC in late 2018. At CNIC, he currently serves as an Associate Professor and Coordinator of the center’s scientific program on "Novel Mechanisms of Atherosclerosis". His research is focused on clonal hematopoiesis and the examination of new mechanisms that link aging to inflammation and cardiovascular disease, with a special focus on the pathophysiology of atherosclerosis and heart failure.
Dr. Fuster's contributions to cardiovascular research have been acknowledged through prestigious awards. Among others, he received the Young Investigator Award from the European Atherosclerosis Society and was recognized as a runner-up for the American Heart Association Irvine H. Page Young Investigator Award.